Pattern of treatment and healthcare costs of secondary hyperparathyroidism in dialysis patients: a real-world evidence analysis.
A. Roggeri, F. Conte, C. Rossi, M. Cozzolino, C. Zocchetti, D.P. Roggeri. Value in Health. November 2019 Volume 22, Supplement 3, Page S920. PUK38
Epidemiologia dell’Iperparatiroidismo secondario nei pazienti CKD in Dialisi: analisi dei Database regionali di Lombardia e Piemonte.
F Conte, DP Roggeri, C Rossi, M Cozzolino, C Zocchetti, A Roggeri. Giornale Italiano di nefrologia. Abstract 60° Congresso Nazionale. Settembre- Ottobre 2019, Anno 36 Vol S.74. PO304
Medical resource use and costs of secondary hyperparathyroidism in dialysis patients in the real-world setting in Lombardy region.
DP Roggeri, F Conte, C Rossi, M Cozzolino, C Zocchetti, A Roggeri. Giornale Italiano di nefrologia. Abstract 60° Congresso Nazionale. Settembre- Ottobre 2019, Anno 36 Vol S.74 PO297
Healthcare resource consumption and costs of SHPT in dialysis patients in the real-world setting in Piedmont region.
DP Roggeri, F Conte, C Rossi, M Cozzolino, C Zocchetti, A Roggeri. Giornale Italiano di nefrologia. Abstract 60° Congresso Nazionale. Settembre- Ottobre 2019, Anno 36 Vol S.74 PO296
Fractures in CKD: risk analysis in RRT Lombardy patients.
F Conte, DP Roggeri, C Rossi, M Cozzolino, C Zocchetti, A Roggeri. Giornale Italiano di nefrologia. Abstract 60° Congresso Nazionale. Settembre- Ottobre 2019, Anno 36 Vol S.74. CO26
Fractures in CKD: risk analysis in rrt Lombardy patients.
F Conte, DP Roggeri, C Rossi, M Cozzolino, C Zocchetti, A Roggeri. Nephrology Dialysis Transplantation, Volume 34, Issue Supplement_1, June 2019, GFZ106.FP712,
Medical resource use and costs of secondary hyperparthyrodism in dialysis patients in the real-world setting.
DP Roggeri, F Conte, C Rossi, M Cozzolino, C Zocchetti, A Roggeri. Nephrology Dialysis Transplantation, Volume 34, Issue Supplement_1, June 2019, gfz103.SP699.
New diagnostic criteria and the costs for treating multiple sclerosis.
M. Petruzzo , R. Palladino , A. Nardone , A. Nozzolillo , G. Servillo , A. Roggeri , D. Roggeri , M. De Angelis , R. Lanzillo , M. Triassi , V. Brescia Morra , M. Moccia. P396. Multiple Sclerosis Journal 2018; 24: (S2) 121–327.
Drug consumption and cost estimates for different recombinant factor VIII products approved for replacement treatment in patients with hemophilia A in Italy.
A Roggeri, E Zanon and DP Roggeri. Haemophilia. 2018;24(Suppl. 1):32–135. P085. DOI: 10.1111/hae.13393
Patterns di utilizzo di eritropoietine nella popolazione in pre-dialisi di Lombardia e Piemonte stimati attraverso l’uso di database amministrativi regionali.
Roggeri DP, Roggeri A, Zocchetti C, Bersani M, Salomone M, Conte F. 57° Congresso Nazionale Società Italiana di Nefrologia, Milano 12-15 ottobre 2016. Poster presentation. Giornale Italiano Di Nefrologia, Libro Degli Abstract 2016, 170 POA.
Utilizzo di eritropoietina nei pazienti in predialisi in Lombardia e Piemonte: analisi dai data base amministrativi.
Conte F, Salomone M, Roggeri DP, Roggeri A. 57° Congresso Nazionale Società Italiana di Nefrologia, Milano 12-15 ottobre 2016. Poster presentation. Giornale Italiano Di Nefrologia, Libro Degli Abstract 2016, 81 POA
Economic burden of the progression of chronic kidney disease estimated through administrative database analysis.
Alessandro Roggeri, Roggeri DP, Zocchetti C, Conte F, on behalf of rene (Lombardy Nephrological Network ). Poster at 52nd Era-Edta Congress, London, UK (may 28-31, 2015). Poster number fp339. Nephrol. Dial. Transplant. (2015) 30 (suppl 3): III181-III182. doi: 10.1093/ndt/gfv175.21
A forecasting model for drug utilization and expenditure integrating a cellular automata model with the budget impact analysis approach. preliminary results.
Joppi R, Demattè L, Guseo R, Jommi C, Mortarino C, Pase D, Poggiani C, Roggeri A, Roggeri DP. Poster at 12nd htai annual meeting, Oslo, Norway (15-17 june 2015).
Impatto economico degli errori di inalazione da cambio di dispositivo inalatorio.
Roggeri A, Micheletto C, Boarino S , Inzillo V, Roggeri DP. Poster XLIII Congresso Nazionale AIPO – Congresso Nazionale FIP. Napoli 11-14 Novembre 2015. poster session.
Il trattamento del tromboembolismo venoso con rivaroxaban in italia: valutazione di impatto sulla spesa del servizio sanitario nazionale.
Roggeri A, Roggeri DP, Pengo V. 3° Congresso SIFAC, “SSN: sostenibilita’ o sopravvivenza? le nuove frontiere dell’assistenza farmaceutica”. Roma 8 – 10 Ottobre 2015. poster presentation.
A forecasting model for drug utilization and expenditure integrating a cellular automata model with the budget impact analysis approach. preliminary results.
Joppi R, Demattè L, Guseo R, Jommi C, Mortarino C, Pase D, Poggiani C, Roggeri A, Roggeri DP. Poster at 12nd htai annual meeting, Oslo, Norway (15-17 june 2015).
Italian Health Economics Association (AIES) 20th annual conference. fostering and governing innovation in healthcare based on evidence. Alghero, 15th – 16th of October 2015. organised session – horizon scanning and budget impact: what can be done to support payers in advance? Chair: Joppi R.
– Forecasting drug utilization and expenditure in Sweden: a tool to promote rational introduction of new medicines.
Wettermark B.
– Cellular automata: pre-launch forecasting of emerging drugs in a category.
Guseo R., Mortarino C.
– Using real world data to assess burden of diabetes.
Cinconze E, Demattè L, Rossi E.
– Budget impact of new anti-diabetes drugs.
Jommi C, Roggeri DP,Roggeri A. .
Administrative data may help registry reliability: experience of Lombardy registry.
Conte F, Limido A, Roggeri A, Roggeri DP, Zocchetti C. On behalf of the Lombardy dialysis registry (rldt), italy. 56° Congresso Nazionale Società Italiana di Nefrologia, Rimini 1-4 Ottobre 2015. poster presentation
Healthcare resource consumption and costs before and after kidney transplantation in Lombardy, Italy.
Roggeri DP, Roggeri A, Zocchetti C, Conte F. value health. 2015 nov;18(7):a513-4. doi: 10.1016/j.jval.2015.09.1488. ISPOR 18th Annual European Congress. 7-11 November 2015 Milan, Italy. poster presentation
Impact on Italian national health service expenditure for the treatment of venous thromboembolism with rivaroxaban.
Roggeri A, Roggeri DP, Pengo V. Value Health. 2015 nov;18(7):a384. doi: 10.1016/j.jval.2015.09.829. ISPOR 18th Annual European Congress. 7-11 November 2015 Milan, Italy. poster presentation
Potential economic impact of inhalation errors due to device switch in patients with chronic obstructive pulmonary disease and asthma
Roggeri A, Micheletto C, Boarino S, Inzillo V, Roggeri DP. Value Health. 2015 nov;18(7):a370. doi: 10.1016/j.jval.2015.09.749. ISPOR 18th Annual European Congress. 7-11 November 2015 Milan, Italy. poster presentation
Integrating drugs budget impact and drugs market uptake models in horizon scanning: the c-tobia model.
Joppi R, Cinconze E, Demattè L, Guseo R, Jommi C, Mortarino C, Pase D, Poggiani C, Roggeri A, Roggeri DP. oral presentation at HTAI Annual Meeting, Tokyo 10-14 may 2016.1.
Direct healthcare Costs Related To End Stage Renal Disease In Patients New To Haemodialysis: The Faro2 Study
Daniela Paola Roggeri, Diego Brancaccio, Mario Cozzolino, Piergiorgio Messa, Giuseppe Cannella, Alessandro Roggeri, Anna Maria Costanzo, Sara Di Fino, Umberto Di Luzio Paparatti, Vincenzo Festa, Sandro Mazzaferro. J Am Soc Nephrol 25: 2014, PUB229 (Abstract Supplement).
Healthcare Costs Of Treating Patients With Overt Hepatic Encephalopathy In Italy.
D.P. Roggeri, A. Roggeri, E. Rossi, E. Cinconze, A. Gasbarrini, P.A. Monici Preti, M. De Rosa. Digestive And Liver Disease Vol. 46 Supplement 4, Pages E131-E132. Oral Presentation as AISF Monothematic Conference, Napoli 9-11 October 2014.
Chronic kidney disease: evolution of healthcare costs and resource consumption from pre-dialysis to dialysis in piedmont region, italy.
Daniela Paola Roggeri, Alessandro Roggeri and Mario Salomone. Poster at International Society of Nephrology, April 3-6 2014, Bergamo.
Comparing costs and consequences of treating COPD with budesonide / formoterol and fluticasone / salmeterol.
Alessandro Roggeri, Michela Pantaleoni, Carlotta Pasina, Veronica Inzillo, Silvia Boarino and Daniela Paola Roggeri Poster c/o xiv congresso nazionale UIP / xlii congresso nazionale aipo, 2013 verona, italy and Poster c/o Ispor 16th annual european congress, 2-6 november 2013, Dublin. Value in health. november 2013(vol. 16, issue 7, page a371).
Patterns of treatment and healthcare costs of patients with acute coronary syndrome receiving dual antiplatelet therapy in piedmont region, Italy.
A Roggeri, R Gnavi, R Rusciani, M Giammaria, M Anselmino, M Dalmasso, T Nicoli and DP Roggeri. Poster Acute Cardiac Care 2013 12 oct 2012 – 14 oct 2013, Madrid.
Outcomes clinici e costi sanitari di pazienti con sindrome coronarica acuta trattati con duplice terapia antiaggregante in regione Piemonte, Italia.
A Roggeri, R Gnavi, R Rusciani, M Giammaria, M Anselmino, M Dalmasso, T Nicoli and DP Roggeri. Poster c/o 44° congresso nazionale di cardiologia, anmco 2013, Firenze.
I costi della sclerosi multipla: analisi derivante da un database amministrativo.
DP. Roggeri, A. Roggeri, C. Jommi. Presentazione orale al 10° convegno nazionale “economia del farmaco e delle tecnologie sanitarie”. Novara, 23 giugno 2011.
Difference in resource consumption and costs of patients with chronic heart failure with and without mitral regurgitation.
D.P. Roggeri, M. Gorini, D. Lucci, L. Tavazzi, A.P. Maggioni on behalf of IN-HF Outcome Investigators. Poster Heart Failure Congress 2012, Belgrado.
Prevalence and outcomes of patients with chronic HF with moderate-severe mitral regurgitation: data from the IN-HF Outcome database.
A.P. Maggioni, M. Gorini, D. Lucci, D.P. Roggeri, L. Tavazzi on behalf of IN-HF Outcome Investigators. Poster Heart Failure Congress 2012, Belgrado.
Use of and adherence to antiplatelet agents after an acute coronary syndrome (ACS): data from a community setting of more than 2,700,000 subjects.
A.P. Maggioni, E. Rossi, E. Cinconze, D.P. Roggeri, A. Roggeri, M. De Rosa on the behalf of the ARNO Cardiovascular Observatory. Poster Acute Cardiac Care 2012, Istanbul.
“Costi sanitari diretti di pazienti con sindrome coronarica acuta in una sottopopolazione del progetto ARNO. focus sul trattamento con duplice terapia antiaggregante con aspirina e clopidogrel”.
Roggeri DP, Roggeri A, Rossi E, Cinconze E, De Rosa M, Maggioni AP a nome dell’osservatorio ARNO. Poster c/o 43° congresso nazionale di cardiologia, ANMCO 2012, Firenze.
Direct sanitary costs of patients with acute coronary syndrome treated with dual antiplatelet treatment with clopidogrel and aspirin in a sub population of the Arno project – Italy.
DP. Roggeri, A. Roggeri, E. Rossi, E. C., M. De Rosa and A.P. Maggioni, on the behalf of the ARNO Cardiovascular Observatory; poster ISPOR US 2012, Washington.
Comparison of investments for different prevention programs: respiratory syncytial virus prophylaxis vs human papilloma vaccine.
M. Soro, R. Sambrook, G. Lorano-Ortega, D. Roggeri , K. L. ; Poster ISPOR congress Madrid 2011.
Evaluation of work-related issues and costs in patients with psoriasis: results from DANIELE study.
Ayala F, Romano GV, Sampogna F, Roggeri DP, Gualberti G, Merolla R, di Luzio Paparatti EADV congress Lisbona 2011.
Resource consumption and social costs of rheumatoid arthritis in a northern Italian Region.
D. P. Roggeri, R. Pellerito, V. Berti, P. L. Canonico. Poster EULAR congress, Roma 2010.
Are the administrative database a strategic tool in decision making? Case study: rheumatoid arthritis in Piemonte Region.
DP Roggeri, V Berti, P Canonico. Poster ISPOR Congress Parigi 2009.
Il controllo farmacologico dell’iperparatiroidismo secondario dei soggetti in emodialisi: una analisi di costi e conseguenze dedotti dallo studio FARO.
DP Roggeri, G Cannella, M Cozzolino, S Mazzaferro, P Messa, D Brancaccio. Poster Convegno SIN, Bologna 2009.
Costi diretti e indiretti di trattamento dell’artrite reumatoide in Piemonte.
DP Roggeri, V Berti, P Canonico. Poster Convegno SIFO, Ascoli Piceno 2009.
Opioid consumption: influence of law changes and new drugs.
A Bortolami, A Chinellato, G Terrazzani, D Roggeri, S Skaper, P Giusti. Poster Convegno SIF 2009.
Modello analitico decisionale per la valutazione dei costi diretti sanitari di trattamento della psoriasi cronica a placche con farmaci biologici.
DP Roggeri, R Di Turi, C Masini; Poster Convegno SIFO 2008.
Il trattamento del dolore nei pazienti terminali: la situazione nella regione veneto.
G. Terrazzani, C. Saramin, P. Deambrosis, A. Chinellato, D. Roggeri, P. Giusti; Poster Convegno SIFO 2006.
Disease severity and costs among patients starting a treatment with cox-2 specific inhibitors versus NSAIDs patients in Italy: quantitative assessment in 442 patients with arthritis.
C. Lucioni, A. Chinellato, S. Mazzi, D. Roggeri, S. Chiroli; Poster ISPOR 2002 Rotterdam, Olanda.
Cost analisys of a 12-week cycle of therapy with celecoxib vs conventional NSAIDs in patients with osteoarthritis.
S. Chiroli, D. Roggeri. Poster ISPOR 2002, Arlington, Virginia.
